Preclinical therapeutic efficacy of a novel pharmacologic inducer of apoptosis in malignant peripheral nerve sheath tumors.
about
A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressorCells of origin in the embryonic nerve roots for NF1-associated plexiform neurofibromaThe role of nerve microenvironment for neurofibroma development.Expression and inhibition of BRD4, EZH2 and TOP2A in neurofibromas and malignant peripheral nerve sheath tumors.Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells.
P2860
Preclinical therapeutic efficacy of a novel pharmacologic inducer of apoptosis in malignant peripheral nerve sheath tumors.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Preclinical therapeutic effica ...... eripheral nerve sheath tumors.
@en
Preclinical therapeutic effica ...... eripheral nerve sheath tumors.
@nl
type
label
Preclinical therapeutic effica ...... eripheral nerve sheath tumors.
@en
Preclinical therapeutic effica ...... eripheral nerve sheath tumors.
@nl
prefLabel
Preclinical therapeutic effica ...... eripheral nerve sheath tumors.
@en
Preclinical therapeutic effica ...... eripheral nerve sheath tumors.
@nl
P2093
P2860
P1433
P1476
Preclinical therapeutic effica ...... eripheral nerve sheath tumors.
@en
P2093
Amish J Patel
Bruce A Posner
Chiachi Liu
Jef K De Brabander
Luis F Parada
Noelle S Williams
Renée M McKay
S Kyun Lim
Shuguang Wei
P2860
P304
P356
10.1158/0008-5472.CAN-13-1934
P407
P577
2013-11-27T00:00:00Z